Pharma, Health IT Stay Strong as Pandemic Slows Deal Volume

Aug. 26, 2020, 9:55 AM UTC

Health-care transactions lagged in July due to headwinds from Covid-19, but year-to-date deals are well ahead of the same period last year, attorneys and analysts say.

The pandemic will likely have an impact on the market beyond the end of the year, according to Epstein Becker & Green attorneys and health industry financial/investment analysts at KPMG and FocalPoint Partners.

The 129 deals announced or closed in July were down slightly from 144 in June and from 161 in July 2019, but they’re still above the monthly average for the second quarter, Larry Kocot, a principal and national leader at KPMG ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.